Article
FGFR2 mutations are rare across histologic subtypes of ovarian cancer.
Gynecologic oncology - 1 Apr 2010
Byron Sara A, Gartside Michael G, Wellens Candice L, Goodfellow Paul J, Birrer Michael J, Campbell Ian G, Pollock Pamela M
Abstract excerpt
OBJECTIVE: Ovarian cancer is the leading cause of death from gynecologic malignancies in the Western world. Fibroblast growth factor receptor (FGFR) signaling has been implicated to play a role in ovarian tumorigenesis. Mutational activation of one member of this receptor family, FGFR2, is a frequent event in endometrioid endometrial cancer. Given the similarities in the histologic and molecular genetics of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
